Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Due to its Drug Affinity Complex (DAC) technology, CJC-1295 DAC has been studied more thoroughly in early clinical trials, where it has shown the capacity to raise circulating growth hormone and insulin-like growth factor-1 (IGF-1) levels for extended periods of time
Therapeutic approaches for Nononcological conditions As previously described, lactate has emerged as a vital mediator in various non-cancerous pathologies, where it functions as more than just a product of metabolism, serving as a signaling agent and modulating the microenvironment
Disulfide Linkers are unique in their cleavable disulfide linker properties, which enable precise drug release via disulfide linker cleavage in highly reductive environments such as tumor cells, minimizing toxicity to normal cells
A medical evaluation is recommended before starting treatment
TB-500 actin-binding affinity utilises pyrene-actin polymerisation assays, measuring fluorescence changes upon actin filament formation
